LOG IN

News

News

United Rheumatology Newsfeed

news-page-logo

2018 Fall National Meeting Presentations Now Available

Presentations from UR’s 2018 Fall National Meeting are now available for viewing and download. Over a dozen presentations covering a wide variety of topics including payer strategies, CMS, clinical pathways, and drug pricing, have been uploaded to the resource section of...
Read More

Healio Newsfeed

2_objects@2x_3

How US-Canada-Mexico trade deal could impact drug prices, research

The United States-Mexico-Canada Agreement keeps biologic drug prices high but could potentially spur new research opportunities, a pharmaceutical expert told Healio Family Medicine.The agreement between the three countries announced on Nov. 30, but … Read moreHow US-Canada-Mexico trade deal could impact drug prices, research

DAPSA-based remission better detects patient-perceived remission in PsA

Remission and low disease activity in psoriatic arthritis, as defined by the Disease Activity Index for Psoriatic Arthritis, better detected patients’ definition of remission and low disease activity compared to “very low disease … Read moreDAPSA-based remission better detects patient-perceived remission in PsA

FDA clears app for patients in treatment for opioid use disorder

The FDA has approved a mobile medical app that could increase the time a patient participates in an outpatient treatment program for opioid use disorder, according to a FDA press release.The app (reSET-O, … Read moreFDA clears app for patients in treatment for opioid use disorder

Hospitalizations longer, costlier for children with juvenile dermatomyositis

Juvenile dermatomyositis increases patients’ hospital stays and inpatient cost of care, particularly among Hispanic and other non-white populations, according to data published in Pediatric Rheumatology.“This study is important because it evaluates which children … Read moreHospitalizations longer, costlier for children with juvenile dermatomyositis

Tofacitinib does not confer meaningful increase in risk for venous thromboembolism

CHICAGO – Treatment with tofacitinib results in a numerically higher, but not statistically significant, risk for venous thromboembolism versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis, according to findings presented at … Read moreTofacitinib does not confer meaningful increase in risk for venous thromboembolism

CreakyJoints Newsfeed

2_objects@2x

How Does Rheumatoid Arthritis Actually Start? New Study Confirms ‘Outside-In’ Hypothesis

Learning how RA develops may ultimately allow doctors to detect and diagnose it sooner. The post How Does Rheumatoid Arthritis Actually Start? New Study Confirms ‘Outside-In’ Hypothesis appeared first on CreakyJoints.

11 Common Questions About Taking Methotrexate for Rheumatoid Arthritis (and Answers to Relieve Your Anxiety)

It’s normal to have questions (okay, a lot of questions) about taking methotrexate. Is it really a cancer drug? Can you drink alcohol? Get answers here. The post 11 Common Questions About Taking … Read more11 Common Questions About Taking Methotrexate for Rheumatoid Arthritis (and Answers to Relieve Your Anxiety)

30 Tips and Tricks to Make Mornings with Arthritis Less Sucky

Say hello to your new best friend: the heated mattress pad. The post 30 Tips and Tricks to Make Mornings with Arthritis Less Sucky appeared first on CreakyJoints.

10 Tricks to Cut Out Sugar and Improve Arthritis Symptoms (and Not Even Miss It)

Overdoing it on added sugar can contribute to inflammation. Here’s how to eat less sugar without quitting cold turkey. The post 10 Tricks to Cut Out Sugar and Improve Arthritis Symptoms (and Not … Read more10 Tricks to Cut Out Sugar and Improve Arthritis Symptoms (and Not Even Miss It)

What It’s Like to Take the Citrate-Free Version of Humira, According to Patients Who’ve Tried It

There’s no burn with this version, patients report. The post What It’s Like to Take the Citrate-Free Version of Humira, According to Patients Who’ve Tried It appeared first on CreakyJoints.

FierceHealthcare Newsfeed

2_objects@2x_1

Healthcare Roundup—Patients admitted during December holidays at higher risk of death, readmission

A new study found that patients discharged from hospital during the December holiday period are less likely to have prompt outpatient follow-up and are at higher risk of death or readmission within 30 … Read moreHealthcare Roundup—Patients admitted during December holidays at higher risk of death, readmission

ZDoggMD: It's time for healthcare to look to version 3.0

Healthcare has had its problems and it’s time to evolve again, according to Zubin Damania, M.D., better known as ZDoggMD on social media. Damania was one of several keynote speakers at the Institute … Read moreZDoggMD: It's time for healthcare to look to version 3.0

Getting health system boards engaged in quality improvement is tricky. IHI releases new framework to help

Quality measurement and improvement has become increasingly complex, and health system board members may struggle to keep up. 

CMS may narrow its focus on drug costs to Part B

The Trump administration has touted its focus on drug prices, unveiling several policy initiatives aimed at reducing costs over the last year. In 2019, it may begin narrowing its focus to Part B, … Read moreCMS may narrow its focus on drug costs to Part B

Olympus to pay $85M after pleading guilty to fraudulently selling scopes linked to superbug spread

The company and a top official pleaded guilty for failing to warn U.S. hospitals about the risk of infection from gastrointestinal scopes despite evidence of risk in Europe.

Rheumatology Advisor Newsfeed

2_objects@2x_2

Unproven But Profitable Stem Cell Clinics

JAMA features a report on the controversy of stem cell treatments for musculoskeletal (MSK) disorders. Stem cell clinics are popular and proliferating as they are largely a cash business and fall outside of … Read moreUnproven But Profitable Stem Cell Clinics

Treat-to-Target in RA: No Increase in AEs

Implementing a treat-to-target approach for the care of rheumatoid arthritis (RA) did not result in an increase in adverse events or resource use, a post-hoc analysis of a randomized trial showed. In an … Read moreTreat-to-Target in RA: No Increase in AEs

Breast Implant Study: More Worries or Not?

The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of  Sjögren’s syndrome, scleroderma, rheumatoid … Read moreBreast Implant Study: More Worries or Not?

An Association between GCA and IBD ?

A population based analysis from Israel suggests that giant cell arteritis (GCA) patients may be at increased risk for  inflammatory bowel diseases (IBD) mainly target. This research was based on sporadic reports in … Read moreAn Association between GCA and IBD ?

FDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized

In response to the growing opioid crisis, the US Food and Drug Administration has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), designed to reduce the risk of abuse, misuse, … Read moreFDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized